ORIENTBIO Inc. (002630) — Capital Reinvestment Ratio
ORIENTBIO Inc. (002630) has a Capital Reinvestment Ratio of 0.26x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩1.77 Billion) in capital expenditures (₩452.25 Million). See ORIENTBIO Inc. net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ORIENTBIO Inc. Capital Reinvestment Ratio (2007–2025)
This chart tracks ORIENTBIO Inc.'s Capital Reinvestment Ratio across 12 annual periods. Check ORIENTBIO Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ORIENTBIO Inc. (2007–2025)
Year-by-year Capital Reinvestment Ratio for ORIENTBIO Inc. from 2007 to 2025. For live market cap and broader valuation context, see 002630 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 6.37x | ₩752.29 Million | ₩4.79 Billion | ▲ +2484.5% |
| 2024 | 0.25x | ₩3.76 Billion | ₩925.25 Million | ▼ -41.2% |
| 2023 | 0.42x | ₩1.16 Billion | ₩485.64 Million | ▼ -55.5% |
| 2022 | 0.94x | ₩2.35 Billion | ₩2.21 Billion | ▲ +3107.8% |
| 2021 | 0.03x | ₩8.74 Billion | ₩256.16 Million | ▼ -99.8% |
| 2016 | 15.85x | ₩912.43 Million | ₩14.46 Billion | ▲ +397.2% |
| 2015 | 3.19x | ₩1.60 Billion | ₩5.11 Billion | ▼ -33.7% |
| 2014 | 4.81x | ₩2.17 Billion | ₩10.43 Billion | ▲ +29.3% |
| 2013 | 3.72x | ₩5.09 Billion | ₩18.94 Billion | ▲ +289.9% |
| 2011 | 0.95x | ₩3.11 Billion | ₩2.97 Billion | ▲ +460.7% |
| 2010 | 0.17x | ₩9.35 Billion | ₩1.59 Billion | ▼ -97.9% |
| 2007 | 8.11x | ₩1.52 Billion | ₩12.30 Billion | — |